In preparation of the conference “Healthcare In Africa”, taking place in Cape Town on March 6 & 7, The Economist Intelligence Unit (EIU), published the report “The Future Of Healthcare In Africa”, commissioned by Janssen Pharmaceutica NV [part of Johnson & Johnson]...Jane Griffiths, Company Group Chairman of Janssen in EMEA, explains : “The study...combin[es] statistics with trends and possible scenarios that could form the basis for further discussions on which policy options to take. Solutions can only become clearer by having open and constructive discussions with all parties involved, based on factual analyses”. Janssen...has...set up a number of projects [in Africa] specifically designed for infectious and neglected diseases, including research for a new tuberculosis treatment in collaboration with the TB Alliance [and] a microbicide targeting HIV, with the International Partnership for Microbicides...For the products that are already approved, Janssen sets up access programmes...